Walled Lake Planning & Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Walled Lake Planning & Wealth Management's ABBV Position: Q2 2026 in Review
Walled Lake Planning & Wealth Management increased its AbbVie (ABBV) stake by 7.8% in Q2 2026, buying an estimated $50.8K and bringing the position to 3,250 shares worth $818K. The position accounts for 0.21% of the portfolio, ranked #56.
Walled Lake Planning & Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 21 quarters since. The position peaked at $7.4M in Q4 2021. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Walled Lake Planning & Wealth Management held 3,250 shares of AbbVie worth $818K as of Q2 2026.
- Walled Lake Planning & Wealth Management bought 236 AbbVie shares in Q2 2026, an estimated $50.8K.
- AbbVie made up 0.21% of Walled Lake Planning & Wealth Management's portfolio in Q2 2026, its #56 holding.
- Walled Lake Planning & Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 21 quarters since.
- Walled Lake Planning & Wealth Management's AbbVie position peaked at $7.4M in Q4 2021.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Walled Lake Planning & Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.